Corporate action official notices
Call Warrants auf Rieter Holding AG
CH1430262084
Call Warrants auf Rieter Holding AG
CH1430262092
Call Warrants auf Rieter Holding AG
CH1455144852
Call Warrants auf Rieter Holding AG
CH1455144860
Call Warrants auf Rieter Holding AG
CH1463731344
Leonteq Securities AG - Übernahme/Fusion/Spin-off (Sponsored Segment)
US08915P1012
Beschrieb: Aufhebung der Zulassung zum Handel aufgrund einer Übernahme/Fusion. Kontakt: David Haab, Leonteq Securities AG, Europaallee 39, 8004 Zürich Telefon: +41 58 800 10 43 E-Mail: david.haab@leonteq.com Letzter Handelstag: 30.09.2025 Datum der Veröffentlichung: 30.09.2025 Für die folgenden Instrumente wird die Zulassung zum Handel aufgehoben (Sponsored Share) ISIN: US08915P1012 Name: Big 5 Sporting Goods Corp
Leonteq Securities AG - Early Redemption
CH1400328147
The following instrument is subject to an early redemption: ISIN CH1400328147 Reason for the redemption: Issuer Call Effective from: 30 September 2025 Publication as of: 1 October 2025
Leonteq Securities AG - Listing of ETP on Saxo Crypto & Blockchain Select Equity NTR Index
CH1292092066
Issuer: Leonteq Securities AG, Zurich, Switzerland Security description/name: Exchange Traded Product on Saxo Crypto & Blockchain Select Equity NTR Index Swiss Security number: 129209206 ISIN: CH1292092066 BX Symbol: SCRYP Issue Size: 8'000'000 Products Currency: CHF Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 17 June 2025 and the performance of the Product is linked to the Saxo Crypto & Blockchain Select Equity NTR Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 30.09.2025. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Leonteq Securities AG - Listing of ETP on Saxo Cyber Security Select Equity NTR Index
CH1292092074
Issuer: Leonteq Securities AG, Zurich, Switzerland Security description/name: Exchange Traded Product on Saxo Cyber Security Select Equity NTR Index Swiss Security number: 129209207 ISIN: CH1292092074 BX Symbol: SCYBE Issue Size: 8'000'000 Products Currency: CHF Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 17 June 2025 and the performance of the Product is linked to the Saxo Cyber Security Select Equity NTR Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 30.09.2025. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Leonteq Securities AG - Listing of ETP on Saxo Defense Select Equity NTR Index
CH1292092090
Issuer: Leonteq Securities AG, Zurich, Switzerland Security description/name: Exchange Traded Product on Saxo Defense Select Equity NTR Index Swiss Security number: 129209209 ISIN: CH1292092090 BX Symbol: SDEFN Issue Size: 2'000'000 Products Currency: CHF Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 17 June 2025 and the performance of the Product is linked to the Saxo Defense Select Equity NTR Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 30.09.2025. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Leonteq Securities AG - Listing of ETP on Saxo Healthcare Innovation Select Equity NTR
CH1292092108
Issuer: Leonteq Securities AG, Zurich, Switzerland Security description/name: Exchange Traded Product on Saxo Healthcare Innovation Select Equity NTR Swiss Security number: 129209210 ISIN: CH1292092108 BX Symbol: SHEAL Issue Size: 8'000'000 Products Currency: CHF Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 17 June 2025 and the performance of the Product is linked to the Saxo Healthcare Innovation Select Equity NTR (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 30.09.2025. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Leonteq Securities AG - Listing of ETPon Saxo Dividend Growth Select Equity NTR Index
CH1292092082
Issuer: Leonteq Securities AG, Zurich, Switzerland Security description/name: Exchange Traded Product on Saxo Dividend Growth Select Equity NTR Index Swiss Security number: 129209208 ISIN: CH1292092082 BX Symbol: SDIVG Issue Size: 8'000'000 Products Currency: CHF Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 17 June 2025 and the performance of the Product is linked to the Saxo Dividend Growth Select Equity NTR Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 30.09.2025. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Long Mini Future auf Amrize Ltd
CH1468207779
Long Mini Future auf DocMorris AG
CH1455138490
Put Warrant on Alibaba ADR
CH1476794750
Put Warrant on Alibaba ADR
CH1476794768
Put Warrant on Alibaba ADR
CH1476794776
Put Warrant on Alibaba ADR
CH1479356797
Strike/Barrier Adjustment SG - 30.09.2025
The following strike/barrier adjustments were made:
W.K. Kellogg Co
US92942W1071
Wintershall Dea Finance 25
XS2054209833
10.00% p.a. Barrier Reverse Convertible on Rolls-Royce Group
CH1381828313
10.20% p.a. Barrier Reverse Convertible on Oracle
CH1447741401
12.40% p.a. Barrier Reverse Convertible on RENK Group
CH1447741385
13.20% p.a. Barrier Reverse Convertible on Commerzbank
CH1447741369